Taiho Ventures
Profile, fund size and portfolio
Taiho Ventures is the corporate venture arm of Taiho Pharmaceutical, a pharmaceutical and biotech company. It was founded in 2016 and is based in Menlo Park, United States. It invests from seed to Series A. Sectors it names: biotech and life sciences, medical devices, healthcare and digital health.
Every figure links to its source
Snapshot
Data behind this graphic
| Measure | Value | Unit | Kind | Source |
|---|---|---|---|---|
| Headline size | USD 400M | AUM or capital under management | Stated by the firm or its parent | S1 |
| Companies backed | 23 | companies | Stated by the firm | S3 |
| Companies on the firm's portfolio page | 23 | companies | Counted from the firm's own list | S3 |
Sources: S1 Taiho Ventures about; S3 Taiho Ventures portfolio.
Where it invests and who leads it
Geography
- Headquarters
- Menlo Park, United States
- Offices
- Menlo Park, United States
Investment regionsS4S1
LeadersS2
- Sakae AsanumaPresident and CEOFind on LinkedInFirm page
- Seiji MiyaharaPartner & Senior Investment DirectorFind on LinkedInFirm page
- Takaaki IshiiSenior Investment DirectorFind on LinkedInFirm page
Key facts
| Fact | Value | Status | Source |
|---|---|---|---|
| Parent company | Taiho Pharmaceutical | Single source | S1 |
| Parent industry | Pharmaceuticals and biotech | Single source | S1 |
| Founded | 2016 | Single source | S2 |
| Headquarters | Menlo Park, United States | Single source | S5 |
| Status | Active | Single source | S1 |
| Capital source | Parent company only | Single source | S1 |
| Headline size | USD 400M (AUM or capital under management) | Single source | S1 |
| Companies backed | 23 | Single source | S3 |
| Stages | Seed, Series A (inferred from announced rounds) | Estimate | S4 |
Portfolio
The firm's portfolio page lists 23 companies.S3
Every company on the Taiho Ventures list
23 companies, as listed on the firm's own website.S3 Read the firm's list.
- Anavo
- Arcus
- Breakpoint Therapeutics
- Cellvie
- Cullinan
- Delphia
- Dren Bio
- Epi Biologics
- Halda
- Harpoon
- Incendia
- Libero Therapeutics
- Light Horse
- Magnet Biomedicine
- NextCure
- Normunity
- ORIC
- Orna
- Storm Therapeutics
- Theolytics
- Transition Bio
- Vertero
- Werewolf
Official pages
Read the firm's own pages for current information.
Sources
- S1Taiho Ventures aboutFirm
- S2Taiho Ventures teamFirm
- S3Taiho Ventures portfolioFirm
- S4Taiho Ventures investment criteriaFirm
- S5Taiho Ventures contactFirm
Disclaimer and corrections
Not affiliated. This page is not affiliated with, endorsed by or sponsored by Taiho Ventures or any company named on it. Names and trademarks belong to their owners. Informational only. This is a public-source reference. It is not investment, legal or tax advice and not an offer or solicitation. Sources. Each figure names its source. Figures may have changed. Please read the firm's official pages, linked above. Corrections and takedown. To report an error or ask for a change or removal, use the correction form or email Richard@CorporateVentureCapital.com.
Spotted a mistake? Report a correction.